4b1820 | Asahi Calpis Wellness Co. Ltd, represented in the European Union by Pen & Tec Consulting S.L.U. | Bacillus subtilis C-3102 (DSM 15544) | Additive composition:Bacillus subtilis C-3102 (DSM 15544) with minimum of 1 × 1010 CFU/gCharacterisation of the active substance:Viable spores (CFU) of Bacillus subtilis C-3102 (DSM 15544)Analytical methodEnumeration: spread plate method using tryptone soya agar (EN 15784:2009)Identification: pulsed-field gel electrophoresis (PFGE). | Chickens for fattening | — | 3 × 108 | — | 1.In the directions for use of the additive and premixture, the storage conditions and stability to heat treatment shall be indicated.2.The use is permitted in feed containing one of the following authorised coccidiostats: monensin sodium, salinomycin sodium, seduramycin sodium, lasalocid sodium, maduramycin ammonium, narasin/nicarbazin, diclazuril.3.For users of the additive and premixtures, feed business operators shall establish operational procedures and organisational measures to address potential risks resulting from their use. Where those risks cannot be eliminated or reduced to a minimum by such procedures and measures, the additive and premixtures shall be used with personal protective equipment, including eye and breathing protection. | 18 June 2029 |